KEMIRIX · Medication Safety · Clinical Decision Support · Drug Interaction Analysis · Pharmacogenomics · For Doctors, Pharmacists & Nurses · Built for Africa · KEMIRIX · Medication Safety · Clinical Decision Support · Drug Interaction Analysis · Pharmacogenomics · For Doctors, Pharmacists & Nurses · Built for Africa ·
KEMIRIX

Global Impact

From Africato the World

Starting in Kenya. Built for 54 countries. Scaling to every emerging market on Earth where clinical intelligence is needed most.

Current focusExpansion roadmapFuture markets

Real-World Use

Clinical Intelligence in Action

These scenarios represent the real clinical situations KEMIRIX is designed to handle — from rural Kenya to urban Nigeria.

Rural Clinic, Western Kenya

A nurse-practitioner in a rural clinic 120km from the nearest hospital sees a patient with fever, anaemia, and joint pain. She enters the symptoms and current medications into KEMIRIX on a tablet with no internet connection. Within seconds, KEMIRIX flags a G6PD deficiency contraindication on the patient's prescribed antimalarial and suggests an alternative. A potential haemolytic crisis is averted.

G6PD contraindication flagged offline

Urban Teaching Hospital, Nairobi

An internal medicine resident in a busy Nairobi teaching hospital is managing a 68-year-old patient on seven medications for diabetes, hypertension, and heart failure. KEMIRIX's polypharmacy engine identifies a previously unrecognised interaction between two of the medications that increases bleeding risk. The prescribing physician adjusts the regimen before the next dispensing cycle.

Polypharmacy interaction prevented

Community Health Worker, Tanzania

A community health worker in rural Tanzania is conducting a household health visit. Using KEMIRIX on her phone, she enters a child's symptoms and weight, and the platform generates a weight-based dosing recommendation with an appropriate antibiotic selection guided by local AMR patterns. The recommendation is displayed in Swahili.

Swahili-language paediatric dosing

Telemedicine Provider, Nigeria

A Lagos-based telemedicine physician is consulting with a patient in Cross River State via video call. The patient mentions taking a traditional herbal preparation alongside his hypertension medications. KEMIRIX identifies a known interaction between the herbal preparation and his ACE inhibitor, prompting the physician to discuss substitution. No other CDS tool in his workflow had this capability.

Traditional medicine interaction identified

Vision

Starting in Kenya. Built for the World.

KEMIRIX begins in Kenya — the continent’s most advanced health tech ecosystem — as a deliberate strategy. Building trust, clinical validation, and regulatory approval in Kenya gives us the foundation to move fast across the continent.

The long-term vision is a world where every healthcare worker — in a Nairobi teaching hospital or a rural clinic in the Rift Valley — has access to the same quality of clinical decision support as a physician at Johns Hopkins.

Phase 1 · 2026–2027
Kenya & East Africa

Hospital pilots in Nairobi, Mombasa, and rural Kenya. Early integration with community health worker programmes.

Phase 2 · 2027–2028
Sub-Saharan Africa

Expansion across 10+ countries. National health system partnerships. Regulatory submissions in target markets.

Phase 3 · 2028+
Global Emerging Markets

Southeast Asia, South Asia, Latin America. Multi-language expansion. Global health system integrations.

Targets

What Success Looks Like

These are targets, not current metrics. Clearly marked as forward-looking projections.

1M+

Drug errors prevented annually at scale

5-year target

50M+

Clinical decisions supported per year

5-year target

200K+

Healthcare workers empowered

5-year target

54

African countries in long-term roadmap

Long-term vision